journal of men's health
Volume 7, Issue 1 , Pages 45-54 , March 2010

Association between family history of cancers and risk of prostate cancer

  • Gayathri Sridhar (MBBS, MPH, PhD)

      Affiliations

    • Virginia Commonwealth University, 830 East Main Street, Suite 5030, P.O. Box 980212, Richmond, VA 23298-0212, USA
    • Corresponding Author InformationCorresponding author.
    • ,
  • Saba W. Masho (MD, MPH, DrPH)

      Affiliations

    • Virginia Commonwealth University, Richmond, VA, USA
    • ,
  • Tilahun Adera (MPH, PhD)

      Affiliations

    • Virginia Commonwealth University, Richmond, VA, USA
    • ,
  • Viswanathan Ramakrishnan (PhD)

      Affiliations

    • Virginia Commonwealth University, Richmond, VA, USA
    • ,
  • John D. Roberts (MD)

      Affiliations

    • Virginia Commonwealth University, Richmond, VA, USA

Received 14 August 2009 ,Accepted 15 October 2009.

References 

  1. American Cancer Society. Cancer Facts & Figures 2008. Atlanta: American Cancer Society; 2008.
  2. Sacco E, Prayer-Galetti T, Pinto F, Ciaccia M, Fracalanza S, Betto G, et al. Familial and hereditary prostate cancer by definition in an Italian surgical series: clinical features and outcome. Eur Urol. 2005;47:761–768
  3. Ahn J, Moslehi R, Weinstein SJ, Snyder K, Virtamo J, Albanes D. Family history of prostate cancer and prostate cancer risk in the alpha-tocopherol, beta-carotene cancer prevention (ATBC) study. Int J Cancer. 2008;123:1154–1159
  4. Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer. 2007;121:1571–1578
  5. Damber L, Gronberg H, Damber JE. Familial prostate cancer and possible associated malignancies: nation-wide register cohort study in sweden. Int J Cancer. 1998;78:293–297
  6. Schuurman AG, Zeegers MP, Goldbohm RA, van den Brandt PA. A case–cohort study on prostate cancer risk in relation to family history of prostate cancer. Epidemiology. 1999;10:192–195
  7. Suzuki T, Matsuo K, Wakai K, Hiraki A, Hirose K, Sato S, et al. Effect of familial history and smoking on common cancer risks in Japan. Cancer. 2007;109:2116–2123
  8. Staples MP, Giles GG, English DR, McCredie MR, Severi G, Cui JS, et al. Risk of prostate cancer associated with a family history in an era of rapid increase in prostate cancer diagnosis (Australia). Cancer Causes Control. 2003;14:161–166
  9. Whittemore AS, Wu AH, Kolonel LN, John EM, Gallagher RP, Howe GR, et al. Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol. 1995;141:732–740
  10. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate. 1990;17:337–347
  11. Ghadirian P, Howe GR, Hislop TG, Maisonneuve P. Family history of prostate cancer: a multi-center case-control study in Canada. Int J Cancer. 1997;70:679–681
  12. Andersson SO, Baron J, Bergstrom R, Lindgren C, Wolk A, Adami HO. Lifestyle factors and prostate cancer risk: a case–control study in Sweden. Cancer Epidemiol Biomarkers Prev. 1996;5:509–513
  13. Keetch DW, Rice JP, Suarez BK, Catalona WJ. Familial aspects of prostate cancer: a case control study. J Urol. 1995;154:2100–2102
  14. Chen YC, Page JH, Chen R, Giovannucci E. Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era. Prostate. 2008;68:1582–1591
  15. Zeegers MP, Jellema A, Ostrer H. Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis. Cancer. 2003;97:1894–1903
  16. Bruner DW, Moore D, Parlanti A, Dorgan J, Engstrom P. Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis. Int J Cancer. 2003;107:797–803
  17. Johns LE, Houlston RS. A systematic review and meta-analysis of familial prostate cancer risk. BJU Int. 2003;91:789–794
  18. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer. N Engl J Med. 2000;343:78–85
  19. Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, Li G, et al. Cumulative association of five genetic variants with prostate cancer. N Engl J Med. 2008;358:910–919
  20. Rodriguez C, Calle EE, Tatham LM, Wingo PA, Miracle-McMahill HL, Thun MJ, et al. Family history of breast cancer as a predictor for fatal prostate cancer. Epidemiology. 1998;9:525–529
  21. Beebe-Dimmer JL, Drake EA, Dunn RL, Bock CH, Montie JE, Cooney KA. Association between family history of prostate and breast cancer among African–American men with prostate cancer. Urology. 2006;68:1072–1076
  22. Hayes RB, Liff JM, Pottern LM, Greenberg RS, Schoenberg JB, Schwartz AG, et al. Prostate cancer risk in U.S. blacks and whites with a family history of cancer. Int J Cancer. 1995;60:361–364
  23. Gronberg H, Bergh A, Damber JE, Emanuelsson M. Cancer risk in families with hereditary prostate carcinoma. Cancer. 2000;89:1315–1321
  24. Cerhan JR, Parker AS, Putnam SD, Chiu BC, Lynch CF, Cohen MB, et al. Family history and prostate cancer risk in a population-based cohort of iowa men. Cancer Epidemiol Biomarkers Prev. 1999;8:53–60
  25. Bai Y, Gao YT, Deng J, Sesterhenn IA, Fraumeni JF, Hsing AW. Risk of prostate cancer and family history of cancer: a population-based study in China. Prostate Cancer Prostatic Dis. 2005;8:60–65
  26. Kalish LA, McDougal WS, McKinlay JB. Family history and the risk of prostate cancer. Urology. 2000;56:803–806
  27. Karakiewicz PI, Foulkes W, Tanguay S, Elhilali MM, Aprikian AG. Familial prostate and breast cancer in men treated with prostatectomy for prostate cancer: a population based case-control study. J Urol. 2003;169:240–244
  28. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst. 1994;86:1600–1608
  29. Negri E, Pelucchi C, Talamini R, Montella M, Gallus S, Bosetti C, et al. Family history of cancer and the risk of prostate cancer and benign prostatic hyperplasia. Int J Cancer. 2005;114:648–652
  30. Hemminki K, Vaittinen P. Effect of paternal and maternal cancer on cancer in the offspring: a population-based study. Cancer Epidemiol Biomarkers Prev. 1997;6:993–997
  31. Eldon BJ, Jonsson E, Tomasson J, Tryggvadottir L, Tulinius H. Familial risk of prostate cancer in Iceland. BJU Int. 2003;92:915–919
  32. Matikaine MP, Pukkala E, Schleutker J, Tammela TL, Koivisto P, Sankila R, et al. Relatives of prostate cancer patients have an increased risk of prostate and stomach cancers: a population-based, cancer registry study in Finland. Cancer Causes Control. 2001;12:223–230
  33. Gallus S, Foschi R, Talamini R, Altieri A, Negri E, Franceschi S, et al. Risk factors for prostate cancer in men aged less than 60 years: a case–control study from Italy. Urology. 2007;70:1121–1126
  34. Isaacs SD, Kiemeney LA, Baffoe-Bonnie A, Beaty TH, Walsh PC. Risk of cancer in relatives of prostate cancer probands. J Natl Cancer Inst. 1995;87:991–996
  35. Randi G, Pelucchi C, Negri E, Talamini R, Galeone C, Franceschi S, et al. Family history of urogenital cancers in patients with bladder, renal cell and prostate cancers. Int J Cancer. 2007;121:2748–2752
  36. Chokkalingam AP, Nyrén O, Johansson JE, Gridley G, McLaughlin JK, Adami HO, et al. Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasia: a population-based cohort study in Sweden. Cancer. 2003;98:1727–1734
  37. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Questionnaire. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2006.
  38. Centers for Disease Control and Prevention (CDC). 2005 Behavioral Risk Factor Surveillance System Survey Questionnaire. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2005.
  39. Centers for Disease Control and Prevention (CDC). 2000 Behavioral Risk Factor Surveillance System Survey Questionnaire. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2000.
  40. National Center for Health Statistics (NCHS). National Health Interview Survey. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2005.
  41. National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2003–2004.
  42. Quillin JM, Ramakrishnan V, Borzelleca J, Bodurtha J, Bowen D, Baer Wilson D. Paternal relatives and family history of breast cancer. Am J Prev Med. 2006;31:265–268
  43. Anon. The Nurses’ Health Study. Boston, MA: Channing Laboratory. Available at http://www.channing.harvard.edu/nhs/questionnaires/index.shtml [Accessed 8/29, 2007].
  44. Dillman DA. Mail and Internet Surveys – the Tailored Design Method. New York: John Wiley and Sons, Inc; 2000;
  45. Arason A, Barkardottir RB, Egilsson V. Linkage analysis of chromosome 17q markers and breast–ovarian cancer in Icelandic families, and possible relationship to prostatic cancer. Am J Hum Genet. 1993;52:711–717
  46. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks of cancer in BRCA1-mutation carriers. breast cancer linkage consortium. Lancet. 1994;343:692–695
  47. Bratt O. Hereditary prostate cancer: clinical aspects. J Urol. 2002;168:906–913
  48. Bratt O, Damber JE, Emanuelsson M, Gronberg H. Hereditary prostate cancer: clinical characteristics and survival. J Urol. 2002;167:2423–2426
  49. Valeri A, Azzouzi R, Drelon E, Delannoy A, Mangin P, Fournier G, et al. Early-onset hereditary prostate cancer is not associated with specific clinical and biological features. Prostate. 2000;45:66–71
  50. Andriole GL, Crawford ED, Grubb RL, Buys SS, Chia D, Church TR, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360(13):1310–1319
  51. Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360(13):1320–1328
  52. Sun J, Zheng SL, Wiklund F, Isaacs SD, Li G, Wiley KE, et al. Sequence variants at 22q13 are associated with prostate cancer risk. Cancer Res. 2009;69:10–15
  53. Johanneson B, McDonnell SK, Karyadi DM, Hebbring SJ, Wang L, Deutsch K, et al. Fine mapping of familial prostate cancer families narrows the interval for a susceptibility locus on chromosome 22q12.3 to 1.36 Mb. Hum Genet. 2008;123:65–75
  54. Camp NJ, Cannon-Albright LA, Farnham JM, Baffoe-Bonnie AB, George A, Powell I, et al. Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for prostate cancer genetics. Hum Mol Genet. 2007;16:1271–1278
  55. Camp NJ, Farnham JM, Cannon-Albright LA. Localization of a prostate cancer predisposition gene to an 880-kb region on chromosome 22q12.3 in Utah high-risk pedigrees. Cancer Res. 2006;66:10205–10212
  56. Bratt O, Kristoffersson U, Lundgren R, Olsson H. Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study. Eur J Cancer. 1999;35:272–277
  57. King TM, Tong L, Pack RJ, Spencer C, Amos CI. Accuracy of family history of cancer as reported by men with prostate cancer. Urology. 2002;59:546–550
  58. American Cancer Society. Guidelines for the Early Detection of Cancer. Available at http://www.cancer.org/docroot/ped/content/ped_2_3x_acs_cancer_detection_guidelines_36.asp [Accessed 10/6, 2009].

PII: S1875-6867(09)00372-8

doi: 10.1016/j.jomh.2009.10.006

journal of men's health
Volume 7, Issue 1 , Pages 45-54 , March 2010

Article Tools